Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
01 2Pharmathen SA
02 3APGDI
03 1Adalvo
04 2Ajanta Pharma Limited
05 2Alkem Laboratories
06 2Alter Laboratories Sa
07 2Apotex Inc
08 19Astellas Pharma
09 1Aurobindo Pharma Limited
10 1Avansor Pharma Oy
11 1CLONMEL HLTHCARE
12 1Cinfa
13 2Cipla Medpro South Africa
14 1GSK
15 2KMS Health Center
16 1LABORATORIOS NORMON SA
17 2Lupin Ltd
18 2MSN Laboratories
19 2Qilu Pharmaceutical
20 2STADA Arzneimittel
21 2Sawai Pharmaceutical Co
22 2Tecnimede
23 2Teva Pharmaceutical Industries
24 2Unichem Laboratories Limited
25 1Whanin Pharmaceutical
26 2Zentiva
27 2Zydus Pharmaceuticals
01 9Depot tablet
02 2ER Tablet
03 8Extended-Release Tablet
04 2FCT
05 1FOR SUSPENSION, EXTENDED RELEASE;ORAL
06 1Granules
07 4Prolonged Release Tablet
08 2Prolonged Release Tablets
09 2Prolonged-Release Tablet
10 2TAB
11 2TABLET (EXTENDED-RELEASE)
12 19TABLET, EXTENDED RELEASE;ORAL
13 10Tablet
01 2Allowed
02 8Approved
03 2Authorised
04 8Authorized
05 4DISCN
06 6Generic
07 2Originator
08 2Prescription
09 15RX
10 15Blank
01 1Baxirto
02 1Bemiga SR
03 15Betmiga
04 1Betmiga 25 mg
05 1Betmiga 50 mg
06 1Iretig
07 17MIRABEGRON
08 4MYRBETRIQ
09 1MYRBETRIQ GRANULES
10 1Mirabegron Adalvo
11 1Mirabegron Advances
12 1Mirabegron Alter
13 1Mirabegron Cinfamed
14 1Mirabegron Clonmel
15 1Mirabegron Glenmark
16 1Mirabegron Normon
17 2Mirabegron Stada
18 2Mirabegron Teva
19 1Mirabegron Zentiva
20 1Urton 25
21 1Urton 50
22 8Blank
01 2Canada
02 2Greece
03 4India
04 2Malta
05 9Norway
06 2Portugal
07 4South Africa
08 1South Korea
09 8Spain
10 8Sweden
11 2Switzerland
12 20USA
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info :
Registration Country : Greece
Brand Name :
Dosage Form : Prolonged Release Tablet
Dosage Strength : 25MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Greece
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info :
Registration Country : Greece
Brand Name :
Dosage Form : Prolonged Release Tablet
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Greece
Regulatory Info : RX
Registration Country : USA
Brand Name : MIRABEGRON
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 25MG
Packaging :
Approval Date : 2025-09-24
Application Number : 218172
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MIRABEGRON
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date : 2025-09-24
Application Number : 218172
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MIRABEGRON
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 25MG
Packaging :
Approval Date : 2024-02-12
Application Number : 215948
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MIRABEGRON
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date : 2024-02-12
Application Number : 215948
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MYRBETRIQ
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 25MG
Packaging :
Approval Date : 2012-06-28
Application Number : 202611
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MYRBETRIQ
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date : 2012-06-28
Application Number : 202611
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MYRBETRIQ GRANULES
Dosage Form : FOR SUSPENSION, EXTENDED RELEASE;ORAL
Dosage Strength : 8MG/ML
Packaging :
Approval Date : 2021-03-25
Application Number : 213801
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : MIRABEGRON
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 25MG
Packaging :
Approval Date : 2025-01-02
Application Number : 209434
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : MIRABEGRON
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date : 2025-01-02
Application Number : 209434
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : MIRABEGRON
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number : 209413
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MIRABEGRON
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 25MG
Packaging :
Approval Date : 2022-09-28
Application Number : 209485
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MIRABEGRON
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date : 2022-09-28
Application Number : 209485
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MIRABEGRON
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 25MG
Packaging :
Approval Date : 2025-06-30
Application Number : 217989
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MIRABEGRON
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date : 2025-06-30
Application Number : 217989
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : MIRABEGRON
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 25MG
Packaging :
Approval Date : 2019-12-27
Application Number : 209446
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : MIRABEGRON
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date : 2025-05-06
Application Number : 217061
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MIRABEGRON
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 25MG
Packaging :
Approval Date : 2022-09-29
Application Number : 209488
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MIRABEGRON
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date : 2022-09-29
Application Number : 209488
Regulatory Info : RX
Registration Country : USA
